ARTEMISMED vs INDRAMEDCO: Stock Comparison

Artemis Medicare Services Limited vs Indraprastha Medical Corporation Limited

Live data: 16 July 2026, 12:37 PM IST • Source: NSE and company filings

Artemis Medicare Services Limited is the larger company by market capitalisation. Artemis Medicare Services Limited shows faster revenue growth, while Indraprastha Medical Corporation Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Artemis Medicare Services Limited and Indraprastha Medical Corporation Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ARTEMISMED is more favourable on 5 of 13 scored metrics and INDRAMEDCO on 8These counts are context-free and are not an overall rating.

Key Differences

Market Cap
ARTEMISMED is the larger company
₹4,395 Cr vs ₹3,437 Cr
P/E Ratio
INDRAMEDCO has a lower P/E
19.06x vs 42.14x
P/B Ratio
ARTEMISMED has a lower P/B
4.67x vs 4.73x
EPS
INDRAMEDCO has higher earnings per share
₹20.04 vs ₹2.29
Dividend Yield
INDRAMEDCO has a higher dividend yield
1.19% vs 0.17%
Revenue Growth (TTM YoY)
ARTEMISMED has faster revenue growth
14.1% vs 9.3%
EPS Growth (TTM YoY)
ARTEMISMED has faster EPS growth
28.7% vs 1.8%
Qtr Sales Growth
ARTEMISMED has stronger quarterly sales growth
16.4% vs 9.31%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricARTEMISMEDINDRAMEDCO
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricARTEMISMEDINDRAMEDCO
Live Price₹277.5₹375.7
Day Change0.47%-0.32%
Volume62,86754,631
52-Week High₹297.5₹640.85
52-Week Low₹203.35₹342
Distance from 52W High-6.72%-41.37%

Valuation

MetricARTEMISMEDINDRAMEDCO
Market Cap₹4,395 Cr₹3,437 Cr
P/E Ratio42.14x19.06x
P/B Ratio4.67x4.73x
EPS₹2.29₹20.04
Book Value₹59.16₹80.78
Dividend Yield0.17%1.19%

Growth

MetricARTEMISMEDINDRAMEDCO
Revenue Growth (TTM YoY)14.1%9.3%
EPS Growth (TTM YoY)28.7%1.8%
Qtr Sales Growth16.4%9.31%
Qtr Profit Growth30.4%1.68%

Profitability & Leverage

MetricARTEMISMEDINDRAMEDCO
ROE12%27.5%
ROCE14.6%35.8%
Net Margin9.58%12.21%
Operating Margin17.4%18%
Debt to Equity0x0x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricARTEMISMEDINDRAMEDCO
Promoter Holding58.39%49.39%
FII Holding12.19% 0.28 pp2.44% 0.29 pp
DII Holding2.89% 0.02 pp0.88% 0.05 pp
Public Holding20.37% 0.29 pp45.69% 0.25 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Artemis Medicare Services Limited and Indraprastha Medical Corporation Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.